Jiwen Cheng

1.9k total citations
82 papers, 1.4k citations indexed

About

Jiwen Cheng is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Jiwen Cheng has authored 82 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 29 papers in Cancer Research and 20 papers in Neurology. Recurrent topics in Jiwen Cheng's work include RNA modifications and cancer (27 papers), Neuroblastoma Research and Treatments (20 papers) and Renal and related cancers (19 papers). Jiwen Cheng is often cited by papers focused on RNA modifications and cancer (27 papers), Neuroblastoma Research and Treatments (20 papers) and Renal and related cancers (19 papers). Jiwen Cheng collaborates with scholars based in China, Macao and Hong Kong. Jiwen Cheng's co-authors include Yi Lv, Muxing Li, Jing He, Wanli Wang, Jiao Zhang, Zhengwen Liu, Jian Dong, Haixia Zhou, Xu‐Feng Zhang and Ying Zhu and has published in prestigious journals such as Applied Physics Letters, PLoS ONE and International Journal of Cancer.

In The Last Decade

Jiwen Cheng

77 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiwen Cheng China 18 640 538 491 269 161 82 1.4k
Junting Huang China 20 318 0.5× 250 0.5× 371 0.8× 139 0.5× 179 1.1× 93 1.0k
Yorihisa Imanishi Japan 20 647 1.0× 358 0.7× 534 1.1× 281 1.0× 118 0.7× 75 1.4k
Paolo D’Amico Italy 17 352 0.6× 305 0.6× 465 0.9× 332 1.2× 254 1.6× 55 1.4k
Stéphane Tercier Switzerland 15 527 0.8× 242 0.4× 350 0.7× 287 1.1× 420 2.6× 40 1.3k
Anuhya Kommalapati United States 18 305 0.5× 177 0.3× 603 1.2× 373 1.4× 254 1.6× 63 1.1k
Philipp von Breitenbuch Germany 9 684 1.1× 176 0.3× 458 0.9× 487 1.8× 178 1.1× 16 1.6k
Katsuhiko Matsuo Japan 17 433 0.7× 178 0.3× 203 0.4× 238 0.9× 151 0.9× 23 1.2k
Zhen Huang China 18 249 0.4× 182 0.3× 480 1.0× 321 1.2× 267 1.7× 104 1.2k

Countries citing papers authored by Jiwen Cheng

Since Specialization
Citations

This map shows the geographic impact of Jiwen Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiwen Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiwen Cheng more than expected).

Fields of papers citing papers by Jiwen Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiwen Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiwen Cheng. The network helps show where Jiwen Cheng may publish in the future.

Co-authorship network of co-authors of Jiwen Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jiwen Cheng. A scholar is included among the top collaborators of Jiwen Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiwen Cheng. Jiwen Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Xianghong, Xing Liu, Zilong Zhang, et al.. (2025). Revealing the role of bisphenol A on prostate cancer progression and identifying potential targets: A comprehensive analysis from population cohort to molecular mechanism. Ecotoxicology and Environmental Safety. 296. 118209–118209. 3 indexed citations
2.
Deng, Changmi, Jinhong Zhu, Fei Duan, et al.. (2025). <i>TRMT10C</i> polymorphisms confer Wilms tumor predisposition: a five-center study. 18(1). 0–0.
4.
Deng, Changmi, Haixia Zhou, Na Zhang, et al.. (2025). ALKBH1 Gene rs6494 T>A Polymorphism Decreases Wilms Tumour Risk in Chinese Children. Journal of Cellular and Molecular Medicine. 29(18). e70864–e70864. 1 indexed citations
5.
Lin, Huiran, Jiabin Liu, Zhonghua Yang, et al.. (2024). Neuroblastoma susceptibility and association of N7-methylguanosine modification gene polymorphisms: multi-center case-control study. Pediatric Research. 97(1). 153–159.
6.
Zhu, Jinhong, Jiao Zhang, Wenli Zhang, et al.. (2023). Identification of hepatoblastoma susceptibility loci in the TRMT6 gene from a seven‐center case–control study. Journal of Cellular and Molecular Medicine. 28(1). e18006–e18006. 6 indexed citations
7.
Chang, Xiaofeng, Jinhong Zhu, Rui‐Xi Hua, et al.. (2023). TRMT6 gene rs236110 C > A polymorphism increases the risk of Wilms tumor. Gene. 882. 147646–147646. 6 indexed citations
8.
Guan, Qian, Huiran Lin, Wenfeng Hua, et al.. (2023). Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression. Chinese Journal of Cancer Research. 35(2). 140–162. 34 indexed citations
9.
Ren, Hui, Zhenjian Zhuo, Fei Duan, et al.. (2021). ALKBH5 Gene Polymorphisms and Hepatoblastoma Susceptibility in Chinese Children. Journal of Oncology. 2021. 1–6. 13 indexed citations
10.
Shen, Cong, Nan Yu, Youmin Guo, et al.. (2021). Computer-aided quantitative MSCT measurements may be useful for congenital lung malformations surgical approach selection. Pediatric Surgery International. 37(9). 1273–1280.
11.
Yang, Zhonghua, Keren Zhang, Yuzuo Bai, et al.. (2021). LIN28A polymorphisms and hepatoblastoma susceptibility in Chinese children. Journal of Cancer. 12(5). 1373–1378. 3 indexed citations
12.
Liu, Jiabin, Rui‐Xi Hua, Yun Cheng, et al.. (2020). <p><em>HMGA2</em> Gene rs8756 A>C Polymorphism Reduces Neuroblastoma Risk in Chinese Children: A Four-Center Case-Control Study</p>. OncoTargets and Therapy. Volume 13. 465–472. 3 indexed citations
13.
Zhuo, Zhenjian, Hongting Lu, Jinhong Zhu, et al.. (2020). METTL14 Gene Polymorphisms Confer Neuroblastoma Susceptibility: An Eight-Center Case-Control Study. Molecular Therapy — Nucleic Acids. 22. 17–26. 46 indexed citations
14.
Liu, Jiabin, Wei Jia, Rui‐Xi Hua, et al.. (2019). APEX1 Polymorphisms and Neuroblastoma Risk in Chinese Children: A Three-Center Case-Control Study. Oxidative Medicine and Cellular Longevity. 2019. 1–8. 7 indexed citations
15.
Li, Le, Jinhong Zhu, Wei Liu, et al.. (2019). Association of miR-34b/c rs4938723 and TP53 Arg72Pro Polymorphisms with Neuroblastoma Susceptibility: Evidence from Seven Centers. Translational Oncology. 12(10). 1282–1288. 6 indexed citations
16.
Cheng, Jiwen, Zhenjian Zhuo, Pu Zhao, et al.. (2019). PARP1 gene polymorphisms and neuroblastoma susceptibility in Chinese children. Journal of Cancer. 10(18). 4159–4164. 8 indexed citations
17.
Li, Yong, Zhenjian Zhuo, Haiyan Zhou, et al.. (2019). H19 gene polymorphisms and neuroblastoma susceptibility in Chinese children: a six-center case-control study. Journal of Cancer. 10(25). 6358–6363. 16 indexed citations
18.
Tian, Jun, et al.. (2013). Effect of erythropoietin on mesenchymal stem cell differentiation and secretion in vitro in an acute kidney injury microenvironment. Genetics and Molecular Research. 12(4). 6477–6487. 10 indexed citations
19.
Cheng, Jiwen, et al.. (2013). Meta-Analysis of the Prognostic and Diagnostic Significance of Serum/Plasma Osteopontin in Hepatocellular Carcinoma. Journal of Clinical Gastroenterology. 48(9). 806–814. 27 indexed citations
20.
Cheng, Jiwen. (1998). Otoacoustic emissions : measurement, data and interrelations. 84(2). 320–328. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026